Isotretinoin and serum thyroid parameters: systematic review and meta-analysis
Anais Brasileiros de Dermatologia · 2026-07 · 101 (4) · 501380
DOI: 10.1016/j.abd.2026.501380 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-07. Verfasst von Niyaz Mostafa und 2 weiteren Autor:innen. Beteiligte Einrichtung: St George Dermatology and Skin Cancer Centre, Sydney, NSW, Australia; Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia. Electron…. Hauptthemen laut MEDLINE: Isotretinoin, Dermatologic Agents, Acne Vulgaris, Thyroid Gland. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Isotretinoin is an effective therapy for acne vulgaris, but its impact on thyroid function remains uncertain, with existing studies reporting inconsistent biochemical changes.
Objective
To assess the effects of oral isotretinoin on serum thyroid function parameters and thyroid antibody levels in patients with acne vulgaris.
Methods
A systematic review and meta-analysis of observational studies was conducted according to PRISMA guidelines and prospectively registered (INPLASY202560049). PubMed, Sco-pus, Embase, and Web of Science were searched from January 1980 to September 2025. Studies reporting serum thyroid parameters before and during isotretinoin therapy were included. Random-effects meta-analyses were performed for parameters reported in more than three studies. Heterogeneity was assessed using the I2 statistic, and risk of bias using NIH tools.
Results
Fifteen studies were included. Meta-analysis showed a small statistically significant increase in thyroid-stimulating hormone after isotretinoin treatment (MD = 0.03, 95% CI 0.02-0.05, p < 0.001), with significant decreases in thyroxine (MD = -0.19, 95% CI -0.24 to -0.15, p < 0.001) and triiodothyronine (MD = -0.62, 95% CI-0.76 - -0.48, p < 0.001). Heterogeneity was substantial for thyroid-stimulating hormone (I2 = 85%) and triiodothyronine (I2 = 86%), and moderate for thyroxine (I2 = 60%). Evidence regarding thyroid antibodies was limited and inconsistent. Study limitations: Included studies were observational, predominantly single-centre, and het-erogeneous in dosing, duration, and laboratory assessments.
Conclusions
Isotretinoin is associated with statistically significant alterations in serum thyroid function parameters, though the clinical significance of these changes remains uncertain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St George Dermatology and Skin Cancer Centre, Sydney, NSW, Australia; Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia. Electronic address: nmostafa.research@gmail.com.
- St George Dermatology and Skin Cancer Centre, Sydney, NSW, Australia; Department of Dermatology, Royal North Shore Hospital, Sydney, NSW, Australia; Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia.
- St George Dermatology and Skin Cancer Centre, Sydney, NSW, Australia.
Zitieren
APA
Mostafa, N., Hong, E., & Stewart, T. (2026). Isotretinoin and serum thyroid parameters: systematic review and meta-analysis. Anais Brasileiros de Dermatologia, 101(4), 501380. https://doi.org/10.1016/j.abd.2026.501380
Vancouver
Mostafa N, Hong E, Stewart T. Isotretinoin and serum thyroid parameters: systematic review and meta-analysis. Anais Brasileiros de Dermatologia. 2026;101(4):501380. doi:10.1016/j.abd.2026.501380
BibTeX
@article{Mostafa2026,
author = {Mostafa, Niyaz and Hong, Esther and Stewart, Thomas},
title = {Isotretinoin and serum thyroid parameters: systematic review and meta-analysis},
journal = {Anais Brasileiros de Dermatologia},
year = {2026},
volume = {101},
number = {4},
pages = {501380},
doi = {10.1016/j.abd.2026.501380}
}
EUVIMED